Abiopharma

🔍 Cyr William B. (Executive)

Company: Freshpet, Inc. (FRPT)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 62,369 shares of Common Stock at $10.23 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 350,862.00 | transaction_form_type: 4
• Sold 40,957 shares of Common Stock at $73.87 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 309,905.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 62,369 shares of Common Stock at $10.23 per share (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 372,274.00 | transaction_form_type: 4
• Sold 40,398 shares of Common Stock at $76.01 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 331,876.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 567 shares of Common Stock at $74.03 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 331,309.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,620 shares of Common Stock at $10.23 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 42,091.00 | transaction_form_type: 4
• Sold 639 shares of Common Stock at $74.34 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 41,452.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,620 shares of Common Stock at $10.23 per share (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,072.00 | transaction_form_type: 4
• Sold 640 shares of Common Stock at $74.03 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 45,432.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 9,030 shares of Common Stock at $10.23 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 92,937.00 | transaction_form_type: 4
• Sold 1,247 shares of Common Stock at $74.34 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 91,690.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 9,030 shares of Common Stock at $10.23 per share (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 100,720.00 | transaction_form_type: 4
• Sold 1,250 shares of Common Stock at $74.03 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 99,470.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,981 shares of Common Stock at $10.23 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 84,673.00 | transaction_form_type: 4
• Sold 1,102 shares of Common Stock at $74.34 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 83,571.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,981 shares of Common Stock at $10.23 per share (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 91,552.00 | transaction_form_type: 4
• Sold 1,105 shares of Common Stock at $74.03 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 90,447.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 62,369 shares of Options to purchase common stock at $10.23 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2026-09-06 | equity_swap_involved: 0 | shares_owned_after: 118,810.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 62,369 shares of Options to purchase common stock at $10.23 per share (Derivative)
  Date: 2026-08-24 | Code: M | Expires: 2026-09-06 | equity_swap_involved: 0 | shares_owned_after: 56,441.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 4,620 shares of Options to purchase common stock at $10.23 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2026-09-06 | equity_swap_involved: 0 | shares_owned_after: 8,800.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 4,620 shares of Options to purchase common stock at $10.23 per share (Derivative)
  Date: 2026-08-24 | Code: M | Expires: 2026-09-06 | equity_swap_involved: 0 | shares_owned_after: 4,180.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 9,030 shares of Options to purchase common stock at $10.23 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2026-09-06 | equity_swap_involved: 0 | shares_owned_after: 17,200.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 9,030 shares of Options to purchase common stock at $10.23 per share (Derivative)
  Date: 2026-08-24 | Code: M | Expires: 2026-09-06 | equity_swap_involved: 0 | shares_owned_after: 8,170.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 7,981 shares of Options to purchase common stock at $10.23 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2026-09-06 | equity_swap_involved: 0 | shares_owned_after: 15,190.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 7,981 shares of Options to purchase common stock at $10.23 per share (Derivative)
  Date: 2026-08-24 | Code: M | Expires: 2026-09-06 | equity_swap_involved: 0 | shares_owned_after: 7,209.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
• F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.819 to $73.874.
• F3: The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
• F4: The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.